Understanding the Market | Chunli Medical rises over 9% again, overseas business has become an important source of income, and third-quarter performance has grown rapidly year-on-year

CHUNLI MEDICAL's stock price rose over 9% again, with a cumulative increase of nearly 25% after the earnings report. As of the time of writing, the stock price is HKD 20.44, with a trading volume of HKD 98.2915 million. The company's operating revenue for the first three quarters was RMB 756 million, a year-on-year increase of 48.75%; net profit was RMB 192 million, a year-on-year increase of 213.21%. The operating revenue for the third quarter was RMB 268 million, a year-on-year increase of 109.51%. Huatai Securities believes that overseas business has become an important source of revenue and expects it to continue to grow rapidly in the future, maintaining a "Buy" rating